Empower Clinics to Open Chicago Medical Cannabis and Wellness Clinic

Exterior View of Empower Clinics' New Chicago Clinic (Photo: Business Wire)

New Illinois measure expands statewide access to medical cannabis as alternative to opioids

Empower Clinics Inc. (CSE: EPW; FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it has established a new clinic in downtown Chicago, as part of the company’s national expansion. This follows the late August signature of a statewide measure by Illinois’ governor to expand access to medical cannabis as an alternative for opioid painkillers.

This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20180912005374/en/

Exterior View of Empower Clinics’ New Chicago Clinic (Photo: Business Wire)

Located in downtown Chicago at 160 N. Upper Wacker Drive, the clinic is slated to open on September 24 and be staffed by licensed medical professionals and support personnel. Empower Clinics offers a variety of physician-guided treatments to address a multitude of chronic pain conditions, as well as anxiety, Post Traumatic Stress Disorder (PTSD) and chemotherapy side effects. The company’s branded line of CBD products will also be available through the clinic. Empower’s “Sollievo” (Italian for “relief”) products have been developed to specifically target the most common qualifying conditions, including pain, sleep disorders, stress, and digestive issues. The products, available as tinctures or topical creams, are non-THC CBD, meaning that they are non-psychotropic: they do not directly affect mood, perception, or consciousness.

ILLINOIS MEASURE OPENS ACCESS TO CANNABIS-BASED TREATMENT

The new Illinois measure, signed into law by Governor Bruce Rauner on August 28, enables doctors to prescribe medical cannabis to any patients who qualify for prescriptions to opioids such as Vicodin, OxyContin, or Percocet. According to the Chicago Tribune, the measure is a response to the epidemic of overdose deaths from narcotics, which killed nearly 2,000 people in Illinois in 2016 and 72,000 people nationwide.

Effective immediately, no qualifying applicants have to undergo fingerprinting or criminal Continue Reading

Comments are closed.